HEADER STRUCTURAL PROTEIN 02-JUN-06 2H7D TITLE SOLUTION STRUCTURE OF THE TALIN F3 DOMAIN IN COMPLEX WITH A CHIMERIC TITLE 2 BETA3 INTEGRIN-PIP KINASE PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TALIN-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: F3 DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CHIMERA OF 24-MER PEPTIDE FROM INTEGRIN BETA-3 AND 10-MER COMPND 9 PEPTIDE FROM PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE TYPE-1 GAMMA; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: CHIMERA OF BETA3-INTEGRIN AND PIP-KINASE; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: TLN1, TLN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-6P2; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS PROTEIN-PEPTIDE COMPLEX, ALPHA HELIX, BETA SHEET, STRUCTURAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.L.WEGENER REVDAT 3 10-NOV-21 2H7D 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 2H7D 1 VERSN REVDAT 1 30-JAN-07 2H7D 0 JRNL AUTH K.L.WEGENER,A.W.PARTRIDGE,J.HAN,A.R.PICKFORD,R.C.LIDDINGTON, JRNL AUTH 2 M.H.GINSBERG,I.D.CAMPBELL JRNL TITL STRUCTURAL BASIS OF INTEGRIN ACTIVATION BY TALIN JRNL REF CELL(CAMBRIDGE,MASS.) V. 128 171 2007 JRNL REFN ISSN 0092-8674 JRNL PMID 17218263 JRNL DOI 10.1016/J.CELL.2006.10.048 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1, CNS 1.1 REMARK 3 AUTHORS : BRUNGER (CNS), BRUNGER (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL OF REMARK 3 2175 RESTRAINTS, OF WHICH 2015 ARE NOE-DERIVED DISTANCE REMARK 3 RESTRAINTS, 126 DIHEDRAL ANGLE RESTRAINTS AND 34 DISTANCE REMARK 3 RESTRAINTS FROM HYDROGEN BONDS. REMARK 4 REMARK 4 2H7D COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038021. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.1 REMARK 210 IONIC STRENGTH : 100MM NACL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.2MM TALIN F3 U-15N; 1.4MM REMARK 210 CHIMERIC PEPTIDE; 50MM PHOSPHATE REMARK 210 BUFFER PH 6.1, 100MM NACL; 95% REMARK 210 H2O, 5% D2O; 1.5MM TALIN F3; REMARK 210 1.5MM CHIMERIC PEPTIDE; 50MM REMARK 210 PHOSPHATE BUFFER PH 6.1, 100MM REMARK 210 NACL; 99.96% D2O; 1.9MM TALIN F3 REMARK 210 U-15N,2H; 1.5MM CHIMERIC PEPTIDE; REMARK 210 50MM PHOSPHATE BUFFER PH 6.1, REMARK 210 100MM NACL; 95% H2O, 5% D2O; REMARK 210 1.9MM TALIN F3 U-15N,2H; 1.5MM REMARK 210 CHIMERIC PEPTIDE; 50MM PHOSPHATE REMARK 210 BUFFER PH 6.1, 100MM NACL; 99.96% REMARK 210 D2O; 0.9MM TALIN F3 U-15N,13C; REMARK 210 1.1MM CHIMERIC PEPTIDE; 50MM REMARK 210 PHOSPHATE BUFFER PH 6.1, 100MM REMARK 210 NACL; 95% H2O, 5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 2D REMARK 210 NOESY; HMQCJ; 2D 1H-15N-13C REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : HOME-BUILT REMARK 210 SPECTROMETER MANUFACTURER : HOME-BUILT REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 2004, SPARKY 3.110 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 323 70.80 -102.91 REMARK 500 1 ASP A 372 70.11 -101.72 REMARK 500 1 TYR A 373 -55.20 -151.99 REMARK 500 1 THR B 720 43.78 -145.82 REMARK 500 1 ILE B 721 -44.40 -151.08 REMARK 500 2 ASP A 372 68.90 -109.65 REMARK 500 2 TYR A 373 -55.84 -139.83 REMARK 500 2 GLU A 384 73.48 -119.02 REMARK 500 2 HIS B 722 -51.07 -130.40 REMARK 500 3 ASP A 372 65.59 -107.58 REMARK 500 3 TYR A 373 -55.24 -153.31 REMARK 500 3 LYS A 404 111.00 65.38 REMARK 500 3 HIS B 722 -53.76 -138.83 REMARK 500 3 ARG B 736 40.69 -105.28 REMARK 500 4 LEU A 306 111.36 66.19 REMARK 500 4 ASP A 372 70.49 -106.47 REMARK 500 4 TYR A 373 -55.66 -150.80 REMARK 500 4 ILE B 721 61.70 61.90 REMARK 500 4 HIS B 722 -54.91 -144.77 REMARK 500 4 ARG B 736 40.95 -106.10 REMARK 500 5 SER A 308 112.71 65.51 REMARK 500 5 ASP A 372 69.64 -104.78 REMARK 500 5 TYR A 373 -55.55 -152.33 REMARK 500 5 ILE B 721 65.75 61.28 REMARK 500 5 HIS B 722 -53.01 -147.49 REMARK 500 6 ASP A 372 71.36 -116.34 REMARK 500 6 TYR A 373 -55.14 -154.08 REMARK 500 6 GLU A 384 73.27 -118.15 REMARK 500 6 ILE B 719 100.44 63.04 REMARK 500 6 HIS B 722 -53.10 -135.15 REMARK 500 6 ALA B 748 -55.64 -137.42 REMARK 500 7 ASP A 372 70.87 -119.70 REMARK 500 7 TYR A 373 -55.06 -150.35 REMARK 500 7 LYS A 404 111.33 65.90 REMARK 500 7 ILE B 721 75.45 60.00 REMARK 500 7 HIS B 722 -50.85 -160.17 REMARK 500 8 ASP A 372 69.92 -110.59 REMARK 500 8 TYR A 373 -55.11 -154.15 REMARK 500 8 ILE B 721 -64.27 74.01 REMARK 500 8 ARG B 736 41.49 -106.28 REMARK 500 9 ASN A 323 65.77 63.95 REMARK 500 9 TYR A 373 -57.81 -132.48 REMARK 500 9 GLU A 384 76.24 -118.13 REMARK 500 9 ILE B 719 112.47 66.75 REMARK 500 9 ILE B 721 -65.96 72.33 REMARK 500 9 ASP B 723 -47.62 86.40 REMARK 500 9 ARG B 736 41.40 -106.19 REMARK 500 10 ASP A 372 69.69 -102.30 REMARK 500 10 TYR A 373 -55.24 -152.53 REMARK 500 10 GLU A 384 71.43 -118.79 REMARK 500 REMARK 500 THIS ENTRY HAS 101 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2H7E RELATED DB: PDB REMARK 900 MINIMIZED AVERAGE STRUCTURE OF THE SAME PROTEIN DBREF 2H7D A 309 405 UNP P54939 TLN1_CHICK 309 405 DBREF 2H7D B 716 739 UNP P05106 ITB3_HUMAN 742 765 DBREF 2H7D B 740 749 UNP O70161 PI51C_MOUS 643 652 SEQADV 2H7D PRO A 305 UNP P54939 CLONING ARTIFACT SEQADV 2H7D LEU A 306 UNP P54939 CLONING ARTIFACT SEQADV 2H7D GLY A 307 UNP P54939 CLONING ARTIFACT SEQADV 2H7D SER A 308 UNP P54939 CLONING ARTIFACT SEQADV 2H7D SER A 336 UNP P54939 CYS 336 ENGINEERED MUTATION SEQADV 2H7D PTR B 741 UNP O70161 TYR 644 MODIFIED RESIDUE SEQRES 1 A 101 PRO LEU GLY SER GLY VAL SER PHE PHE LEU VAL LYS GLU SEQRES 2 A 101 LYS MET LYS GLY LYS ASN LYS LEU VAL PRO ARG LEU LEU SEQRES 3 A 101 GLY ILE THR LYS GLU SER VAL MET ARG VAL ASP GLU LYS SEQRES 4 A 101 THR LYS GLU VAL ILE GLN GLU TRP SER LEU THR ASN ILE SEQRES 5 A 101 LYS ARG TRP ALA ALA SER PRO LYS SER PHE THR LEU ASP SEQRES 6 A 101 PHE GLY ASP TYR GLN ASP GLY TYR TYR SER VAL GLN THR SEQRES 7 A 101 THR GLU GLY GLU GLN ILE ALA GLN LEU ILE ALA GLY TYR SEQRES 8 A 101 ILE ASP ILE ILE LEU LYS LYS LYS LYS SER SEQRES 1 B 34 LYS LEU LEU ILE THR ILE HIS ASP ARG LYS GLU PHE ALA SEQRES 2 B 34 LYS PHE GLU GLU GLU ARG ALA ARG ALA LYS TRP VAL PTR SEQRES 3 B 34 SER PRO LEU HIS TYR SER ALA ARG MODRES 2H7D PTR B 741 TYR O-PHOSPHOTYROSINE HET PTR B 741 24 HETNAM PTR O-PHOSPHOTYROSINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 2 PTR C9 H12 N O6 P HELIX 1 1 GLU A 384 LYS A 403 1 20 HELIX 2 2 ILE B 721 ARG B 736 1 16 SHEET 1 A 8 VAL A 347 SER A 352 0 SHEET 2 A 8 SER A 336 VAL A 340 -1 N VAL A 337 O TRP A 351 SHEET 3 A 8 LEU A 325 ILE A 332 -1 N LEU A 329 O VAL A 340 SHEET 4 A 8 SER A 311 LYS A 318 -1 N SER A 311 O ILE A 332 SHEET 5 A 8 TYR A 378 THR A 382 -1 O GLN A 381 N LYS A 316 SHEET 6 A 8 SER A 365 PHE A 370 -1 N PHE A 366 O VAL A 380 SHEET 7 A 8 ILE A 356 ALA A 361 -1 N ALA A 360 O THR A 367 SHEET 8 A 8 TRP B 739 PTR B 741 -1 O VAL B 740 N TRP A 359 LINK C VAL B 740 N PTR B 741 1555 1555 1.35 LINK C PTR B 741 N SER B 742 1555 1555 1.35 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1